Interferon-Alpha and Cancer

 

 

Interferon-alpha side effect profile

Clinical Studies

Interferon-a as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series

Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study

Interferon/Controlled study in 3-year survival of patients with osteosarcoma

ATRA and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma

Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study

Interferon-alpha and angiogenesis

Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis pdf

Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways

Interferon-alpha·: Regulatory Effects on Cell Cycle and Angiogenesis

 

Pathology Research Interferon and Osteosarcoma cells
Interferon-a Enhances the Sensitivity of Human Osteosarcoma Cells to Etoposide

Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells

 

Interferon-Gamma

Interferon-gamma Sensitizes Osteosarcoma Cells to Fas-Induced Apoptosis by Up-Regulating Fas Receptors and Caspase-8

Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells

 

Depression, Cognitive Impairment associated with Interferon-alpha

Prevention of interferon-alpha associated depression

Alpha-interferon and mental disorders

Early Depressive Symptoms in Cancer Patients Receiving Interleukin 2 and/or Interferon Alfa-2b Therapy

Cytokine-Induced Sickness Behavior: Mechanisms and Implications

Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study

Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha